Nanovis received FDA 510(k) clearance to market FortiCore® interbody fusion devices that feature a Nanosurface-enhanced porous titanium scaffold, intermolded with a PEEK core.
The devices are intended for use in transforaminal and anterior lumbar interbody fusion procedures (TLIF and ALIF). The nanopatterned surface is intended to target fixation-related complications; it also forms the basis of a bactericidal program under development to address infection-related complications
FortiCore devices received initial FDA clearance in 2014. Since then, over 4,250 units have been implanted; this is an increase from the milestone of the 2,000th implantation, noted in 1Q17.
Sources: Nanovis; ORTHOWORLD Inc.
